17 October 2017
News and Views
Links and Services
fiogf49gjkf04The latest issue of the Alimentary Pharmacology & Therapeutics examines the the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.
Levofloxacin triple therapy has been used for the first-line and second-line treatment
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors